by ACvA | Jul 22, 2019 | News Features
ACvA today (July 22) held its second Annual Strategy Day at the iconic Shine Dome, Australian Academy of Science in the Nation’s Capital, Canberra. Around 36 experts including ACvA Board Members, Flagship Directors, researchers, clinicians, industry, Health and...
by ACvA | Jul 15, 2019 | Latest News, News Features
It has been a busy time building the ACvA team, with the recent appointment of several (honorary) Director positions. The calibre of applicants was outstanding, and a number of positions will benefit from Co-Directorship. Congratulations go to: Industry and...
by ACvA | Jul 5, 2019 | News Features
ACvA’s objective to create a national strategic platform tosupport academic–industry partnership was launched at itsinaugural ACvA Industry Round Table, which was held at theShine Dome, in Canberra with generous support by the Academyof Science. Facilitated by Chris...
by ACvA | May 30, 2019 | News Features
NEW YORK — As the number of American adults dying of cancer continues to decline, the number who are dying of heart disease is on the rise, according to a new report.Researchers at the US Centers for Disease Control and Prevention’s National Center for Health...
by ACvA | Feb 26, 2019 | News Features
The Federal Government today committed $220 million from the Medical Research Future Fund (MRFF) to breakthrough research in the fight against cardiovascular disease, the country’s leading cause of death. The funding will support a Mission for Cardiovascular Health...
by ACvA | Feb 20, 2019 | News Features
A large Australian-led international study involving over 19,000 people averaging 74 years of age has found there is no benefit in taking daily aspirin to prolong a healthy life and that instead of a benefit, there is potential for harm. While aspirin has become one...
